MICROSTREP PLUS TYPE 1 PANELS
Report
- Report Number
- 2919016-2014-00016
- Event Type
- Malfunction
- Date Received
- April 1, 2014
- Date of Event
- March 7, 2014
- Report Date
- March 7, 2014
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Product Code
- LTT
- Removal / Correction Number
- Z-1272-2013
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
SIEMENS HAD CONDUCTED A FIELD CORRECTION, (B)(4), FOR FALSE SKIPPED WELLS AND FALSE SUSCEPTIBLE MISREADS WITH S. AGALACTIAE AFFECTING MULTIPLE ANTIMICROBIAL AGENTS ON MICROSCAN MICROSTREP PLUS TYPE 1 PANELS (B1027-201), MICROSTREP PLUS TYPE 5 PANELS (B1016-905), MICROFAST TYPE 5J PANELS (J1016-83) AND MICROFAST TYPE 7J PANELS (J1016-84). THE CUSTOMER LETTER STATED RESULTS SHOULD BE VISUALLY VERIFIED FOR S. AGALACTIAE ISOLATES ON THE ABOVE PANEL TYPES. ADDITIONALLY ALL SUBSEQUENT LOTS WERE MANUFACTURED WITH UPDATED INFO ON THIS LIMITATION. SIEMENS CONFIRMED THAT THIS CUSTOMER RECEIVED THE INITIAL CUSTOMER NOTIFICATION ASSOCIATED WITH FDA RECALL (B)(4) AND THAT THE LOT WAS MANUFACTURED WITH THE UPDATED INFO (CONFIRMED THROUGH A REVIEW OF THE MANUFACTURING RECORDS).
A CUSTOMER COMPLAINT WAS RECEIVED FOR S. AGALACTIAE ISOLATE WITH SUSCEPTIBLE RESULTS FOR ERYTHROMYCIN USING A WALKAWAY BUT VISUALLY THE RESULTS WERE RESISTANT. PANELS WERE VISUALLY VERIFIED AND THE CORRECT "RESISTANT" RESULTS WERE REPORTED TO THE PHYSICIAN. THERE WAS NO ADVERSE IMPACT TO PATIENT TREATMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 194298 | MICROSTREP PLUS TYPE 1 PANELS | MICROSTREP PLUS TYPE 1 | LTT | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2014-08-05 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |